Related Experiment Video
Updated: Jul 31, 2026

Delivery of Therapeutic Agents Through Intracerebroventricular (ICV) and Intravenous (IV) Injection in Mice
Published on: October 3, 2011
Gentamicin treatment in McArdle disease: failure to correct myophosphorylase deficiency
A Schroers1, R A Kley, A Stachon
1Department of Neurology, Neuromuscular Center Ruhrgebiet, Ruhr University, Bochum, Germany.
No abstract available in PubMed .
More Related Videos
10:16In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
Published on: December 20, 2017
10:01High-Throughput Optical Controlling and Recording Calcium Signal in iPSC-Derived Cardiomyocytes for Toxicity Testing and Phenotypic Drug Screening
Published on: March 31, 2022
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Heart Failure Drugs: Inotropic Agents
Myocarditis III: Medical Management
Cardiomyopathy V: Interprofessional Care
Myasthenia Gravis ll: Pathophysiology